Cerus

(CERS) - Get Report

was one of the best performers of Friday's session. After the previous close, the biotech company said it swung to a fourth-quarter profit that easily beat Wall Street's estimates. Cerus was recently up 33 cents, or 5.8%, to $6.07.

Telik

(TELK)

was also higher after the company late Thursday posted a narrower-than-expected fourth-quarter loss. The stock was rising 38 cents, or 7%, to $5.85.

On the other hand,

Gene Logic

( GLGC) slid 4.2% to $1.82 after the company said it may spin off its genomics division, which was once the company's core business.

PDL BioPharma

(PDLI) - Get Report

was also moving lower more than a day after the company missed fourth-quarter earnings targets. The stock was losing 26 cents, or 1.3%, to $19.45.

Among health care winners of the session,

NeoPharm

( NEOL) surged 29.8% to $2.31.

Celgene

(CELG) - Get Report

was adding 2.8% at $56.41.

GlaxoSmithKline

(GSK) - Get Report

was higher by 1.1% to $57.

Among decliners,

Forest Laboratories

(FRX)

was off 1.2% at $54.34.

Humana

(HUM) - Get Report

was losing 1.1% to $61.61.

UnitedHealth Group

(UNH) - Get Report

was down 1% to $53.19.